Your browser doesn't support javascript.
loading
Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.
Curik, Nikola; Laznicka, Adam; Polivkova, Vaclava; Krizkova, Jitka; Pokorna, Eva; Semerak, Pavel; Suchankova, Pavla; Burda, Pavel; Hochhaus, Andreas; Machova Polakova, Katerina.
Afiliação
  • Curik N; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Laznicka A; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Polivkova V; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Krizkova J; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Pokorna E; Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Semerak P; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Suchankova P; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Burda P; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Hochhaus A; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Machova Polakova K; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
Leukemia ; 38(6): 1415-1418, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38615117

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridazinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Crise Blástica / Imidazóis / Mutação Limite: Animals / Humans Idioma: En Revista: Leukemia Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridazinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Crise Blástica / Imidazóis / Mutação Limite: Animals / Humans Idioma: En Revista: Leukemia Ano de publicação: 2024 Tipo de documento: Article